1,174
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Hybrid liposomes showing enhanced accumulation in tumors as theranostic agents in the orthotopic graft model mouse of colorectal cancer

, &
Pages 1192-1199 | Received 12 Apr 2018, Accepted 08 May 2018, Published online: 23 May 2018

References

  • Allen TM, Hansen C, Martin F, et al. (1991). Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29–36.
  • André T, Boni C, Mounedji-Boudiaf L, et al. (2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–51.
  • Baohong Y, NanGuang C, Quing Z. (2004). Emission and absorption properties of indocyanine green in Intralipid solution. Biomed Opt 9:497–503.
  • Bokemeyer C, Bondarenko I, Hartmann JT, et al. (2011). Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study. Ann Oncol 22:1535–46.
  • De Gasperi A, Mazza E, Prosperi M. (2016). Indocyanine green kinetics to assess liver function: ready for a clinical dynamic assessment in major liver surgery? World J Hepatol 8:355–67.
  • Deliconstantinos G. (1987). Physiological aspects of membrane lipid fluidity in malignancy. Anticancer Res 7:1011–21.
  • Ferlay J, Soerjomataram I, Dikshit R, et al. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86.
  • Furukawa T, Kubota T, Watanabe M, et al. (1993). Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histologically-intact tumor tissue in nude mice. Anticancer Res 13:287–91.
  • Hoekstra LT, de Graaf W, Nibourg GA, et al. (2013). Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg 257:27–36.
  • Hoffman AG, Kuksis A. (1980). Culture of presumptive epithelial cells from jejunal mucosa of axenic rats. Experientia 36:202–4.
  • Hoffman RM. (1999). Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17:343–59.
  • Hoffman RM. (2017). Patient-derived mouse models of cancer. Molecular and translational medicine. Gewerbestrasse (Cham): Springer Intl. Publishing AG.
  • Ichihara H, Hino M, Umebayashi M, et al. (2012). Intravenous injection of hybrid liposomes suppresses the liver metastases in xenograft mouse models of colorectal cancer in vivo. Eur J Med Chem 57:143–8.
  • Ichihara H, Nagami H, Kiyokawa T, et al. (2008). Chemotherapy using hybrid liposomes along with induction of apoptosis. Anticancer Res 28:1187–95.
  • Ichihara H, Nakagawa S, Matsuoka Y, et al. (2014). Nanotherapy with hybrid liposomes for colorectal cancer along with apoptosis in vitro and in vivo. Anticancer Res 34:4701–8.
  • Ichihara H, Yamasaki S, Hino M, et al. (2015). Hybrid liposomes inhibit the growth and angiogenesis in human breast cancer model. J Carcinog Mutagen 6:1000207–1-7.
  • Itoh T, Tanioka M, Matsuda H, et al. (1999). Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177–81.
  • Iwamoto Y, Matsumoto Y, Ueoka R. (2005). Induction of apoptosis of human lung carcinoma cells by hybrid liposomes containing polyoxyethylenedodecyl ether. Int J Pharm 292:231–9.
  • Kitamura I, Kochi M, Matsumoto Y, et al. (1996). Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Cancer Res 56:3986–92.
  • Komizu Y, Matsumoto Y, Ueoka R. (2006). Membrane targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis. Bioorg Med Chem Lett 16:6131–4.
  • Komizu Y, Nakata S, Goto K, et al. (2011). Membrane-targeted nanotherapy with hybrid liposomes for tumor cells leading to apoptosis. ACS Med Chem Lett 2:275–9.
  • Komizu Y, Ueoka H, Ueoka R. (2012). Selective accumulation and growth inhibition of hybrid liposomes to human hepatocellular carcinoma cells in relation to fluidity of plasma membranes. Biochem Biophys Res Commun 418:81–6.
  • Komizu Y, Yukihara M, Kariya R, et al. (2011). Selective accumulation of hybrid liposomes into adult T-cell leukemia cells along with induction of apoptosis. Bioorg Med Chem Lett 21:3962–5.
  • Liebes LF, Pelle E, Zucker-Franklin D, Silber R. (1981). Comparison of lipid composition and 1,6-diphenyl-1,3,5-hexatriene fluorescence polarization measurements of hairy cells with monocytes and lymphocytes from normal subjects and patients with chronic lymphocytic leukemia. Cancer Res 41:4050–6.
  • Longley DB, Harkin DP, Johnston PG. (2003). 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330–8.
  • Maarek JM, Holschneider DP, Harimoto J, et al. (2004). Measurement of cardiac output with indocyanine green transcutaneous fluorescence dilution technique. Anesthesiology 100:1476–83.
  • Matsumoto Y, Iwamoto Y, Matsushita T, Ueoka R. (2005). Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int J Cancer 115:377–82.
  • Matsumoto Y, Kato T, Iseki S, et al. (1999). Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells. Bioorg Med Chem Lett 9:1937–40.
  • Nagami H, Nakano K, Ichihara H, et al. (2006). Two methylene groups in phospholipids distinguish between apoptosis and necrosis for tumor cells. Bioorg Med Chem Lett 16:782–5.
  • Papahadjopoulos D, Poste G, Schaeffer BE. (1973). Fusion of mammalian cells by unilamellar lipid vesicles: influence of lipid surface charge, fluidity and cholesterol. Biochim Biophys Acta 323:23–42.
  • Quaroni A, Wands J, Trelstad RL, Isselbacher KJ. (1979). Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 80:248–65.
  • Shimoda S, Ichihara H, Matsumoto Y, Ueoka R. (2009). Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo. Int J Pharm 372:162–8.
  • Sok M, Sentjurc M, Schara M. (1999). Membrane fluidity characteristics of human lung cancer. Cancer Lett 139:215–20.
  • Taieb J, Balogoun R, Le Malicot K, et al. (2017). Adjuvant FOLFOX +/− cetuximab in full RAS and BRAF wildtype stage III colon cancer patients. Ann Oncol 28:824–30.
  • Ueoka R, Matsumoto Y, Moss RA, et al. (1988). Membrane matrix for the hydrolysis of amino acid esters with marked enantioselectivity. J Am Chem Soc 110:1588–95.
  • Ueoka R, Moss RA, Swarup S, et al. (1985). Extraordinary micellar enantioselectivity coupled to altered aggregate structure. J Am Chem Soc 107:2185–6.
  • Vos JJ, Wietasch JK, Absalom AR, et al. (2014). Green light for liver function monitoring using indocyanine green? An overview of current clinical applications. Anaesthesia 69:1364–76.